Format

Send to

Choose Destination

See 1 citation found using an alternative search:

J Am Coll Cardiol. 2015 May 26;65(20):2225-38. doi: 10.1016/j.jacc.2015.03.567.

Bleeding avoidance strategies during percutaneous coronary interventions.

Author information

1
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: singh.mandeep@mayo.edu.

Abstract

Bleeding avoidance strategies for percutaneous coronary interventions continue to evolve with the availability of newer antiplatelet and anticoagulation therapies. Advances in interventional practices have altered the balance between ischemic and bleeding complications. With the availability of rapidly-acting platelet adenosine diphosphate-receptor antagonists, the need for routine glycoprotein IIb/IIIa inhibitors has diminished. Recent meta-analyses and trials have advanced our knowledge of vascular access and different anticoagulation regimens. Vascular closure devices have long been used for early ambulation; however, more recent results demonstrating lower bleeding complications from observational registries are encouraging. This review synthesizes this information, taking into account changes in the landscape of interventional practice with respect to current bleeding avoidance strategies.

KEYWORDS:

anticoagulants; platelet aggregation inhibitors; thrombosis; vascular closure devices

PMID:
25998668
DOI:
10.1016/j.jacc.2015.03.567
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center